WHO is despondent there is not much interest in new vaccines rolled out on September 1
by Alison Ryan
The statement by WHO, released on 22 September 2022, indicates that the G20 initiative ACT-Accelerator and their Council Tracking and Accelerating Progress working group, co-chaired by Indonesia and the United States, are “despondent that interest in the new vaccines, rolled out on September 1, has “stagnated”” (merylnass.substack.com/p/no-time-for-covid-complacency-says).
“No time for COVID-19 complacency, say the key countries, Indonesia and the United States, responsible for tracking global rollout of COVID-19 vaccines, tests and treatments” (www.who.int/news/item/22-09-2022-no-time-for-covid-19-complacency–say-key-countries-responsible-for-tracking-global-rollout-of-covid-19-vaccines–tests-and-treatments).
They still theorize that the “global threat” of COVID-19 is far from over, particularly for high-risk groups in lower-income countries, and according to their most recent Global COVID Access Tracker data, around a quarter of those most vulnerable globally still need a primary COVID-19 vaccination series (24% of elderly persons and 26% of health workers).
The medical crime lies within their conclusions that, “The swift, equitable roll-out of vaccines, tests, and treatments is crucial to help countries combat COVID-19. Without adequate testing and sequencing, the world is blind to the evolution of the virus and potential new variants. People in low and middle-income countries continue to die due to a lack of access to antiviral treatments and oxygen. We must push on for equitable access to COVID-19 tools, despite multiple competing priorities.”
And, of course, the lead partner agencies of ACT-Accelerator, CEPI, FIND, Gavi, The Global Fund, UNICEF, Unitaid, Wellcome, WHO, the World Bank and The Bill & Melinda Gates Foundation, are “the only global, end-to-end solution” to the pandemic that never ended “as a global emergency in 2022”.